GLAXO / NSE / Biotechnology & Drugs
GlaxoSmithKline Pharmaceuticals
1Y Price Trend
Key Information
Recommendations
RatingBuy
Target High3,356
Target Low2,088
Target Mean2
Target Median25
Risk Metrics
Overall RiskBalanced risk
Board Risk26.35
Key Analysis
Overall score, performance score, return rating, defensive, aggressive, and balanced views.
Download appProjection Analytics
Best-case, base-case, worst-case, and dynamic AI projection views.
Download appLatest stock news
Glaxosmithkline Pharmaceuticals Ltd Faces Bearish Momentum Amid Technical Downgrade Markets Mojo
Glaxosmithkline Pharmaceuticals Ltd is Rated Sell Markets Mojo
GSK Pharma recommends ₹57 dividend, sets AGM date scanx.trade
Five Consecutive Losses Push Glaxosmithkline Pharmaceuticals Ltd to a New 52-Week Low Markets Mojo
Markets Rally, But Glaxosmithkline Pharmaceuticals Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off Markets Mojo
GSK Pharma Compliance Officer resigns effective August 5, 2026 scanx.trade
Glaxosmithkline Pharmaceuticals Ltd Falls to 52-Week Low of Rs 2215 as Sell-Off Deepens Markets Mojo
Glaxosmithkline Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Market Signals Markets Mojo
Stock FAQs
What is the symbol and ISIN of GlaxoSmithKline Pharmaceuticals?
GlaxoSmithKline Pharmaceuticals has the symbol GLAXO and ISIN - INE159A01016.
What is the current price of GlaxoSmithKline Pharmaceuticals?
GlaxoSmithKline Pharmaceuticals is currently trading at INR 2,439.60.
What are the year high and year low of GlaxoSmithKline Pharmaceuticals?
GlaxoSmithKline Pharmaceuticals has a year high of INR 3,356.00 and a year low of INR 2,088.00.
What is the market capitalization of GlaxoSmithKline Pharmaceuticals?
GlaxoSmithKline Pharmaceuticals has a market capitalization of INR 41,715.98 crore.
What is the P/E ratio of GlaxoSmithKline Pharmaceuticals?
GlaxoSmithKline Pharmaceuticals has a P/E ratio of 37.33.
What is the dividend yield of GlaxoSmithKline Pharmaceuticals?
GlaxoSmithKline Pharmaceuticals has a dividend yield of 2.34%.
How is the financial performance of GlaxoSmithKline Pharmaceuticals based on revenue, net income, and EPS?
GlaxoSmithKline Pharmaceuticals has revenue of INR 38,216.75 crore, net income of INR 10,359.82 crore, and EPS of INR 60.26.
What is the book value of GlaxoSmithKline Pharmaceuticals?
GlaxoSmithKline Pharmaceuticals has a book value of INR 133.46.
What is the debt-to-equity ratio of GlaxoSmithKline Pharmaceuticals?
GlaxoSmithKline Pharmaceuticals has a debt-to-equity ratio of NA.
What are the price-to-book and price-to-sales ratios of GlaxoSmithKline Pharmaceuticals?
GlaxoSmithKline Pharmaceuticals has a price-to-book ratio of 18.28 and a price-to-sales ratio of 1.09.
© SharekeyX | Rusaka Technologies 2024-2026